Alumis dips day after listless Nasdaq debut

Alumis

01/07/2024 18:25

** Shares of biopharmaceutical firm Alumis  ALMS.O  drop 3%
on their second day of trading after tepid Nasdaq debut
    ** Stock is 20% off its $16 IPO price as enthusiasm for new
share sales fades following a resurgence sparked by the likes of
Reddit  RDDT.N 
    ** ALMS raised $210 mln in its downsized IPO after setting a
target of at least $282 mln earlier
    ** ALMS, looking to develop oral therapies to address immune
dysfunction, is yet to generate any revenue

 (Reporting by Niket Nishant in Bengaluru)
 ((Niket.Nishant@thomsonreuters.com))